193 related articles for article (PubMed ID: 35500171)
1. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Ono M; Onuma Y; Kawashima H; Hara H; Gao C; Wang R; O'Leary N; Benit E; Janssens L; Ferrario M; Żurakowski A; Dominici M; Huber K; Buszman P; Garg S; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Windecker S; Vranckx P; Deliargyris EN; Bhatt DL; Storey RF; Valgimigli M; Serruys PW;
Catheter Cardiovasc Interv; 2022 Jul; 100(1):72-82. PubMed ID: 35500171
[TBL] [Abstract][Full Text] [Related]
2. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
[TBL] [Abstract][Full Text] [Related]
4. Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.
Serruys PW; Tomaniak M; Chichareon P; Modolo R; Kogame N; Takahashi K; Chang CC; Spitzer E; Walsh SJ; Adlam D; Hildick-Smith D; Édes I; van de Harst P; Krackhardt F; Tijssen JGP; Rademaker-Havinga T; Garg S; Steg PG; Hamm C; Jüni P; Vranckx P; Onuma Y; Verheugt FWA
EuroIntervention; 2019 Dec; 15(12):e1090-e1098. PubMed ID: 30888959
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.
Ono M; Hara H; Kawashima H; Gao C; Wang R; Wykrzykowska JJ; Piek JJ; Garg S; Hamm C; Steg PG; Valgimigli M; Windecker S; Vranckx P; Onuma Y; Serruys PW
EuroIntervention; 2022 Aug; 18(5):e377-e388. PubMed ID: 35260381
[TBL] [Abstract][Full Text] [Related]
6. Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.
Hara H; van Klaveren D; Takahashi K; Kogame N; Chichareon P; Modolo R; Tomaniak M; Ono M; Kawashima H; Wang R; Gao C; Niethammer M; Fontos G; Angioi M; Ribeiro VG; Barbato E; Leandro S; Hamm C; Valgimigli M; Windecker S; Jüni P; Steg PG; Verbeeck J; Tijssen JGP; Sharif F; Onuma Y; Serruys PW;
Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006660. PubMed ID: 32762446
[TBL] [Abstract][Full Text] [Related]
7. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.
Ono M; Chichareon P; Tomaniak M; Kawashima H; Takahashi K; Kogame N; Modolo R; Hara H; Gao C; Wang R; Walsh S; Suryapranata H; da Silva PC; Cotton J; Koning R; Akin I; Rensing BJWM; Garg S; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Steg PG; Valgimigli M; Windecker S; Storey RF; Onuma Y; Vranckx P; Serruys PW
Clin Res Cardiol; 2020 Sep; 109(9):1125-1139. PubMed ID: 32006156
[TBL] [Abstract][Full Text] [Related]
8. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
[TBL] [Abstract][Full Text] [Related]
9. Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trials.
Shoji S; Kuno T; Ueyama H; Takagi H; Briasoulis A; Kim HS; Koo BK; Kang J; Watanabe H; Kimura T; Kohsaka S
J Cardiol; 2024 May; 83(5):338-347. PubMed ID: 37562542
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.
Takahashi K; Serruys PW; Chichareon P; Chang CC; Tomaniak M; Modolo R; Kogame N; Magro M; Chowdhary S; Eitel I; Zweiker R; Ong P; Ottesen MM; Tijssen JGP; Wykrzykowska JJ; de Winter RJ; Garg S; Stoll HP; Hamm C; Steg PG; Onuma Y; Valgimigli M; Vranckx P; Carrie D; Windecker S
J Am Coll Cardiol; 2019 Oct; 74(16):2015-2027. PubMed ID: 31623758
[TBL] [Abstract][Full Text] [Related]
11. Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial.
Tomaniak M; Chichareon P; Takahashi K; Kogame N; Modolo R; Chang CC; Spitzer E; Neumann FJ; Plante S; Hernández Antolin R; Jambrik Z; Gelev V; Brunel P; Konteva M; Beygui F; Morelle JF; Filipiak KJ; van Geuns RJ; Soliman O; Tijssen J; Rademaker-Havinga T; Storey RF; Hamm C; Steg PG; Windecker S; Onuma Y; Valgimigli M; Serruys PW;
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):222-230. PubMed ID: 31876907
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
Kogame N; Chichareon P; De Wilder K; Takahashi K; Modolo R; Chang CC; Tomaniak M; Komiyama H; Chieffo A; Colombo A; Garg S; Louvard Y; Jüni P; G Steg P; Hamm C; Vranckx P; Valgimigli M; Windecker S; Stoll HP; Onuma Y; Janssens L; Serruys PW
Catheter Cardiovasc Interv; 2020 Jul; 96(1):100-111. PubMed ID: 31410968
[TBL] [Abstract][Full Text] [Related]
13. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.
Chichareon P; Modolo R; Kerkmeijer L; Tomaniak M; Kogame N; Takahashi K; Chang CC; Komiyama H; Moccetti T; Talwar S; Colombo A; Maillard L; Barlis P; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Mehran R; Serruys PW
JAMA Cardiol; 2020 Jan; 5(1):21-29. PubMed ID: 31693078
[TBL] [Abstract][Full Text] [Related]
14. 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.
Gamal AS; Hara H; Tomaniak M; Lunardi M; Gao C; Ono M; Kawashima H; Jüni P; Vranckx P; Windecker S; Hamm C; Steg PG; Onuma Y; Serruys PW
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):756-773. PubMed ID: 34212187
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
Kim BK; Hong SJ; Cho YH; Yun KH; Kim YH; Suh Y; Cho JY; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon H; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
JAMA; 2020 Jun; 323(23):2407-2416. PubMed ID: 32543684
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).
Kawashima H; Tomaniak M; Ono M; Wang R; Hara H; Gao C; Takahashi K; Sharif F; Thury A; Suryapranata H; Walsh S; Cotton J; Carrie D; Sabate M; Steinwender C; Leibundgut G; Wykrzykowska J; de Winter RJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
Am J Cardiol; 2021 Jan; 138():1-10. PubMed ID: 33065080
[TBL] [Abstract][Full Text] [Related]
17. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
Tomaniak M; Chichareon P; Onuma Y; Deliargyris EN; Takahashi K; Kogame N; Modolo R; Chang CC; Rademaker-Havinga T; Storey RF; Dangas GD; Bhatt DL; Angiolillo DJ; Hamm C; Valgimigli M; Windecker S; Steg PG; Vranckx P; Serruys PW;
JAMA Cardiol; 2019 Nov; 4(11):1092-1101. PubMed ID: 31557763
[TBL] [Abstract][Full Text] [Related]
18. Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial.
Ono M; Tomaniak M; Koenig W; Khamis R; de Silva R; Chichareon P; Kawashima H; Hara H; Gao C; Wang R; Huber K; Vrolix M; Jasionowicz P; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Steg PG; Windecker S; Onuma Y; Storey RF; Serruys PW
Eur Heart J Cardiovasc Pharmacother; 2022 Jan; 8(1):39-47. PubMed ID: 32956446
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
Obayashi Y; Watanabe H; Morimoto T; Yamamoto K; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
Circ Cardiovasc Interv; 2022 Aug; 15(8):e012004. PubMed ID: 35912647
[TBL] [Abstract][Full Text] [Related]
20. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
